secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76387 grounded facts newest September 3, 2026, 5:10 PM ET RSS · JSON

Showing 7851–7900 of 76387

Departed

Eeva Hakoranta

Chief Licensing Officer
IDCC · InterDigital, Inc.
Effective
2025-04-04
Filed
April 7, 2025, 7:59 PM ET
Effective April 4, 2025, Eeva Hakoranta will no longer be serving as Chief Licensing Officer.
Departed

Robert C. Griffin

Chairman of the Board
CVGI · Commercial Vehicle Group, Inc.
Successor
William C. Johnson
Filed
April 7, 2025, 7:59 PM ET
On April 2, 2025, Robert C. Griffin, a director of the Company since July 2005, and current Chairman of the Board of the Company, informed the Company that he will be retiring from the Board of the Company, without standing for re-election at the 2025 Annual Meeting of Stockholders.
Appointed

John Costa

Member of the Board of Directors
CITR · CitroTech Inc.
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, the majority voting stockholder of General Enterprise Ventures, Inc. (the “Corporation”) approved the appointment of the following persons as members of the Board of Directors (the “Board”) of the Corporation, effective April 1, 2025: Theodore Ralston Jeffrey Pomerantz John Costa
Appointed

Nanuk Warman

Secretary and Chief Financial Officer
CITR · CitroTech Inc.
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, the Board of the Corporation approved the appointment of the following persons as officers (each, an “Officer” and collectively, the “Officers”) of the Corporation, effective April 1, 2025: Theodore Ralston President and Chief Executive Officer Nanuk Warman Secretary and Chief Financial Officer Joshua Ralston Vice President of Operations Anthony Newton General Counsel
Appointed

Anthony Newton

General Counsel
CITR · CitroTech Inc.
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, the Board of the Corporation approved the appointment of the following persons as officers (each, an “Officer” and collectively, the “Officers”) of the Corporation, effective April 1, 2025: Theodore Ralston President and Chief Executive Officer Nanuk Warman Secretary and Chief Financial Officer Joshua Ralston Vice President of Operations Anthony Newton General Counsel
Appointed

Joshua Ralston

Vice President of Operations
CITR · CitroTech Inc.
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, the Board of the Corporation approved the appointment of the following persons as officers (each, an “Officer” and collectively, the “Officers”) of the Corporation, effective April 1, 2025: Theodore Ralston President and Chief Executive Officer Nanuk Warman Secretary and Chief Financial Officer Joshua Ralston Vice President of Operations Anthony Newton General Counsel
Appointed

Theodore Ralston

Member of the Board of Directors
CITR · CitroTech Inc.
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, the majority voting stockholder of General Enterprise Ventures, Inc. (the “Corporation”) approved the appointment of the following persons as members of the Board of Directors (the “Board”) of the Corporation, effective April 1, 2025: Theodore Ralston Jeffrey Pomerantz John Costa
Appointed

Theodore Ralston

President and Chief Executive Officer
CITR · CitroTech Inc.
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, the Board of the Corporation approved the appointment of the following persons as officers (each, an “Officer” and collectively, the “Officers”) of the Corporation, effective April 1, 2025: Theodore Ralston President and Chief Executive Officer Nanuk Warman Secretary and Chief Financial Officer Joshua Ralston Vice President of Operations Anthony Newton General Counsel
Appointed

Jeffrey Pomerantz

Member of the Board of Directors
CITR · CitroTech Inc.
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, the majority voting stockholder of General Enterprise Ventures, Inc. (the “Corporation”) approved the appointment of the following persons as members of the Board of Directors (the “Board”) of the Corporation, effective April 1, 2025: Theodore Ralston Jeffrey Pomerantz John Costa
Departed

Kenneth M. Greenwood

Chief Product Architect
SSGC · SafeSpace Global Corp
Effective
2025-04-04
Filed
April 7, 2025, 7:59 PM ET
On April 4, 2025, Kenneth M. Greenwood, Chief Product Architect, notified Healthcare Integrated Technologies, Inc. (the “Company”) of his resignation from all positions with the Company, effective immediately.
Departed

Michael R. Edwards

Division President – Famous Footwear
CAL · CALERES INC
Effective
2025-05-02
Filed
April 4, 2025, 7:59 PM ET
On March 31, 2025, Michael R. Edwards notified Caleres, Inc. (the “Company”) of his decision to resign as the Company’s Division President – Famous Footwear, effective May 2, 2025.
Appointed (interim)

Randy Kanai

Interim Chief Accounting Officer
NORDSTROM INC
Effective
2025-04-01
Filed
April 4, 2025, 7:59 PM ET
On April 1, 2025 , the Board of Directors (the “Board”) of Nordstrom, Inc. appointed the Corporation’s Vice President – Controller, Randy Kanai, age 50, to the position of Interim Chief Accounting Officer.
Departed

Gerald Ng

Vice President and Chief Financial Officer
DAIO · DATA I/O CORP
Filed
April 4, 2025, 7:59 PM ET
Retirement of Gerald Ng: Gerald Ng, Vice President and Chief Financial Officer of Data I/O Corporation (the “Company”), announced his planned retirement and upcoming transition, which is expected to take place in the second quarter of 2025.
Appointed

Kevin D. Chapman

Director
RNST · RENASANT CORP
Filed
April 4, 2025, 7:59 PM ET
appointed Kevin D. Chapman, Renasant’s President and Chief Operating Officer and a member of the Bank Board, to fill this new seat on the Board
Role change

Kevin D. Chapman

Chief Executive Officer
RNST · RENASANT CORP
Effective
2025-05-01
Filed
April 4, 2025, 7:59 PM ET
Kevin D. Chapman assuming the role of the Company’s and the Bank’s Chief Executive Officer on the Transition Date (as previously disclosed)
Appointed

Renee Moore

Director
RNST · RENASANT CORP
Filed
April 4, 2025, 7:59 PM ET
appointed each of M. Ray (Hoppy) Cole, Jr., Jonathan A. Levy, Renee Moore, and Ted E. Parker to fill the new seats on the Board, effective as of the Effective Time
Appointed

Ted E. Parker

Director
RNST · RENASANT CORP
Filed
April 4, 2025, 7:59 PM ET
appointed each of M. Ray (Hoppy) Cole, Jr., Jonathan A. Levy, Renee Moore, and Ted E. Parker to fill the new seats on the Board, effective as of the Effective Time
Appointed

Jonathan A. Levy

Director
RNST · RENASANT CORP
Filed
April 4, 2025, 7:59 PM ET
appointed each of M. Ray (Hoppy) Cole, Jr., Jonathan A. Levy, Renee Moore, and Ted E. Parker to fill the new seats on the Board, effective as of the Effective Time
Appointed

M. Ray (Hoppy) Cole, Jr.

Director
RNST · RENASANT CORP
Filed
April 4, 2025, 7:59 PM ET
appointed each of M. Ray (Hoppy) Cole, Jr., Jonathan A. Levy, Renee Moore, and Ted E. Parker to fill the new seats on the Board, effective as of the Effective Time
Departed

E. Robinson McGraw

Executive Chairman
RNST · RENASANT CORP
Effective
2025-05-01
Filed
April 4, 2025, 7:59 PM ET
E. Robinson McGraw, the Company’s Executive Chairman and the Chairman of the Board and of the Bank Board, agreed with the Company that he would resign as an officer and employee of the Company and the Bank, effective May 1, 2025 (the “Transition Date”)
Departed

Eiry W. Roberts

Chief Medical Officer
NBIX · NEUROCRINE BIOSCIENCES INC
Effective
2025-06-02
Successor
Sanjay Keswani
Filed
April 4, 2025, 7:59 PM ET
Dr. Keswani will succeed Dr. Roberts, who has served as Chief Medical Officer for the past seven years, and who agreed to remain with the Company in a strategic advisory role following her succession by Dr. Keswani.
Appointed

Sanjay Keswani

Chief Medical Officer
NBIX · NEUROCRINE BIOSCIENCES INC
Effective
2025-06-02
Filed
April 4, 2025, 7:59 PM ET
On April 2, 2025, Sanjay Keswani, M.D. agreed to succeed Eiry W. Roberts, M.D. as the Chief Medical Officer of Neurocrine Biosciences, Inc. (“Neurocrine Biosciences” or the “Company”), effective June 2, 2025.
Appointed

Scott Garula

Executive Vice President & Chief Financial Officer
CTAS · CINTAS CORP
Effective
2025-06-01
Filed
April 4, 2025, 7:59 PM ET
On April 1, 2025, the Company appointed Scott Garula, currently President of Cintas’ Rental Division, to succeed Mr. Hansen as Executive Vice President & CFO, effective June 1, 2025.
Role change

J. Michael Hansen

Executive Vice President & Chief Financial Officer
CTAS · CINTAS CORP
Effective
2025-05-31
Successor
Scott Garula
Filed
April 4, 2025, 7:59 PM ET
J. Michael Hansen notified Cintas Corporation (the “Company”) of his intent to retire from his role as Executive Vice President & Chief Financial Officer (“CFO”).
Departed

Thomas Krywe

Interim Chief Financial Officer, principal financial officer and principal accounting officer
SPIR · Spire Global, Inc.
Effective
2025-04-01
Successor
Alison Engel
Filed
April 4, 2025, 7:59 PM ET
on March 18, 2025, the Board approved, effective on April 1, 2025, (i) the removal of Thomas Krywe as interim Chief Financial Officer, principal financial officer and principal accounting officer of the Company and (ii) the appointment of Alison Engel as Chief Financial Officer, principal financial officer and principal accounting officer of the Company.
Appointed

Alison Engel

Chief Financial Officer, principal financial officer and principal accounting officer
SPIR · Spire Global, Inc.
Effective
2025-04-01
Filed
April 4, 2025, 7:59 PM ET
on March 18, 2025, the Board approved, effective on April 1, 2025, (i) the removal of Thomas Krywe as interim Chief Financial Officer, principal financial officer and principal accounting officer of the Company and (ii) the appointment of Alison Engel as Chief Financial Officer, principal financial officer and principal accounting officer of the Company.
Departed

Kathy Vrabeck

Chief Operating Officer
BODI · Beachbody Company, Inc.
Effective
2025-04-01
Filed
April 4, 2025, 7:59 PM ET
Kathy Vrabeck retired from the Company as its Chief Operating Officer, effective as of April 1, 2025.
Departed

Paul L. Berns

Director
Unity Biotechnology, Inc.
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
On April 3, 2025, Paul L. Berns informed the Board of Directors (the “Board”) of UNITY Biotechnology, Inc. (“Unity” or the “Company”) of his resignation as a member of the Board of the Company, and all of the committees of the Board on which he serves, in each case, effective at the close of business on April 4, 2025.
Departed

Marc Wilson

Other
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2025-04-01
Filed
April 4, 2025, 7:59 PM ET
pursuant to which Mr. Wilson resigned as an employee of the Company, effective April 1, 2025
Departed

Ramesh Gopalakrishnan

Director
BHE · BENCHMARK ELECTRONICS INC
Effective
2025-05-14
Filed
April 4, 2025, 7:59 PM ET
Each of Ramesh Gopalakrishnan and Jeffrey S. McCreary notified the Board of Directors (the “Board”) of Benchmark Electronics, Inc. (the “Company”) on April 2, 2025 and April 3, 2025, respectively, of his intent not to stand for re-election at the Company’s 2025 annual meeting of shareholders to be held on May 14, 2025 (the “Meeting”) upon the expiration of his term.
Departed

Jeffrey S. McCreary

Director
BHE · BENCHMARK ELECTRONICS INC
Effective
2025-05-14
Filed
April 4, 2025, 7:59 PM ET
Each of Ramesh Gopalakrishnan and Jeffrey S. McCreary notified the Board of Directors (the “Board”) of Benchmark Electronics, Inc. (the “Company”) on April 2, 2025 and April 3, 2025, respectively, of his intent not to stand for re-election at the Company’s 2025 annual meeting of shareholders to be held on May 14, 2025 (the “Meeting”) upon the expiration of his term.
Appointed

Glynis A. Bryan

Director
BHE · BENCHMARK ELECTRONICS INC
Effective
2025-05-14
Filed
April 4, 2025, 7:59 PM ET
the Board has nominated Glynis A. Bryan, retired Chief Financial Officer of Insight Enterprises, Inc. (NASDAQ:NSIT), for election to the Board at the Meeting.
Departed

L. Jay Cross

President
HHH · Howard Hughes Holdings Inc.
Effective
2025-12-01
Filed
April 4, 2025, 7:59 PM ET
On April 2, 2025, the Company and its President, L. Jay Cross, mutually agreed not to renew Mr. Cross’ employment agreement upon the expiration of its current term on December 1, 2025, which shall be treated as a non-renewal by the Company under his employment agreement.
Departed

James B. Miller, Jr.

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Departed

W. Dennis Hogue

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Departed

Thomas L. Newberry, V.

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Appointed

Telukutla Venkata Nasara Reddy

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
the directors of Merger Sub immediately prior to the Effective Time, which consisted of Telukutla Venkata Nasara Reddy and Katherine Dunn, became the directors of the surviving corporation.
Departed

Allan Dow

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Departed

Celena Matlock

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Appointed

Brad Debold

Other Named Officer
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
the following persons became officers of the Company: Telukutla Venkata Nasara Reddy, Brad Debold and Katherine Dunn.
Appointed

Katherine Dunn

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
the directors of Merger Sub immediately prior to the Effective Time, which consisted of Telukutla Venkata Nasara Reddy and Katherine Dunn, became the directors of the surviving corporation.
Departed

Matthew G. McKenna

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Appointed

Katherine Dunn

Other Named Officer
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
the following persons became officers of the Company: Telukutla Venkata Nasara Reddy, Brad Debold and Katherine Dunn.
Departed

Lizanne Thomas

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Departed

Nicole Wu

Director
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
Appointed

Telukutla Venkata Nasara Reddy

Other Named Officer
LOGILITY SUPPLY CHAIN SOLUTIONS, INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
the following persons became officers of the Company: Telukutla Venkata Nasara Reddy, Brad Debold and Katherine Dunn.
Appointed

Wayde McMillan

Director
HOLOGIC INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
increased the size of the Board from eight to nine directors and appointed Wayde McMillan as a director of the Company, effective April 4, 2025.
Appointed

Wayde McMillan

director
HOLOGIC INC
Effective
2025-04-04
Filed
April 4, 2025, 7:59 PM ET
appointed Wayde McMillan as a director of the Company, effective April 4, 2025.
Appointed

Peter J. Weiler

Chief Financial Officer
EDSA · Edesa Biotech, Inc.
Effective
2025-05-01
Filed
April 4, 2025, 7:59 PM ET
the Company appointed Peter J. Weiler to serve as the Company’s Chief Financial Officer, effective May 1, 2025
Departed

Stephen Lemieux

Chief Financial Officer
EDSA · Edesa Biotech, Inc.
Effective
2025-05-01
Successor
Peter J. Weiler
Filed
April 4, 2025, 7:59 PM ET
Stephen Lemieux, Chief Financial Officer of Edesa Biotech, Inc. (the “Company”), notified the Company of his intention to resign from his position and responsibilities as Chief Financial Officer, effective May 1, 2025, to pursue another professional opportunity.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.